Clinical Trial Update: A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH [Phase 2]

View source ↗

Summary

A Phase 2 trial of elobixibat in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis has completed, with results posted in September 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Elobixibat (elobixibat)

Snippet

Sponsor: Albireo | Conditions: NAFLD, NASH | Phase 2 | Status: COMPLETED | Results posted: 2021-09-27